期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
Reoperation for heterochronic intraductal papillary mucinous neoplasm of the pancreas after bile duct neoplasm resection:A case report 被引量:1
1
作者 Gang Xiao Tao Xia +1 位作者 Yi-Ping Mou Yu-Cheng Zhou 《World Journal of Gastrointestinal Surgery》 SCIE 2023年第7期1542-1548,共7页
BACKGROUND Intraductal papillary neoplasm of the bile duct(IPNB)and intraductal papillary mucinous neoplasm(IPMN)of the pancreas have similar pathological manifestations.However,they often develop separately and it is... BACKGROUND Intraductal papillary neoplasm of the bile duct(IPNB)and intraductal papillary mucinous neoplasm(IPMN)of the pancreas have similar pathological manifestations.However,they often develop separately and it is rare for both to occur together.Patients presenting with heterochronic IPMN after IPNB are prone to be misdiagnosed with tumor recurrence.CASE SUMMARY A 67-year-old male patient was admitted 8.5 years after IPNB carcinoma and 4 years after the discovery of a pancreatic tumor.A left hepatic bile duct tumor with distal bile duct dilatation was found 8.5 years ago by the computed tomography;therefore,a left hepatectomy was performed.The postoperative pathological diagnosis was malignant IPNB with negative cutting edge and pathological stage T1N0M0.Magnetic resonance imaging 4 years ago showed cystic lesions in the pancreatic head with pancreatic duct dilatation,and carcinoembryonic antigen continued to increase.Positron emission tomography showed a maximum standard uptake value of 11.8 in the soft tissue mass in the pancreatic head,and a malignant tumor was considered.Radical pancreatoduodenectomy was performed.Postoperative pathological diagnosis was pancreatic head IPMN with negative cutting edge,pancreaticobiliary type,stage T3N0M0.He was discharged 15 d after the operation.Follow-up for 6 mo showed no tumor recurrence,and quality of life was good.CONCLUSION IPNB and IPMN are precancerous lesions with similar pathological characteristics and require active surgery and long-term follow-up. 展开更多
关键词 Intraductal papillary neoplasm of the bile duct Intraductal papillary mucinous neoplasm of the pancreas PANCREATODUODENECTOMY Heterochronous tumor REOPERATION Case report
下载PDF
Solid pseudopapillary neoplasm of the pancreas 被引量:9
2
作者 Ayo O Omiyale 《World Journal of Hepatology》 2021年第8期896-903,共8页
Solid pseudopapillary neoplasms are rare.This article reviews the clinical and pathologic features of solid pseudopapillary neoplasm of the pancreas,including the epidemiology,cytology,molecular pathology,differential... Solid pseudopapillary neoplasms are rare.This article reviews the clinical and pathologic features of solid pseudopapillary neoplasm of the pancreas,including the epidemiology,cytology,molecular pathology,differential diagnosis,treatment,and prognosis.Solid pseudopapillary neoplasms are low-grade malignant tumours of the pancreas characterized by poorly cohesive epithelial cells with solid and pseudopapillary patterns.Solid pseudopapillary neoplasms occur predominantly in young women.Although solid pseudopapillary neoplasms can occur throughout the pancreas,they arise slightly more frequently in the tail of the pancreas.The aetiology is unknown.Extremely rare cases have been reported in the setting of familial adenomatous polyposis.There are no symptoms unique to solid pseudopapillary neoplasms,however,the most common symptom is abdominal pain or discomfort.The features of solid pseudopapillary neoplasms on computed tomography imaging are indicative of the pathologic changes within the tumour.Typically,well-demarcated masses with variably solid and cystic appearances.Microscopically,these tumours are composed of epithelial cells forming solid and pseudopapillary structures,frequently undergoing haemorrhagic cystic degeneration.Typically,these tumours express nuclear and/or cytoplasmicβ-catenin.Almost all solid pseudopapillary neoplasms harbour mutations in exon 3 of CTNNB1,the gene encodingβ-catenin.The overall prognosis is excellent,and most patients are cured by complete surgical resection. 展开更多
关键词 Cancer of pancreas Pancreatic neoplasms Solid pseudopapillary neoplasm of the pancreas Non-ductal pancreatic tumours pancreas
下载PDF
Surgical treatment for uncinate process carcinoma of the pancreas 被引量:1
3
作者 Sen Li Yong-Quan Pei +5 位作者 Fu-Tian Du Guan-Yi Zhuang Chun-You Li Qin-Hua Song Wei Ding Jian-Li Wang the Department of Hepatobiliary Surgery, Weifang People’s Hospital, Weifang 261041, China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2002年第4期592-594,共3页
Objectives: To analyze the clinical features of unci- nate process carcinoma of the pancreas and to im- prove the resection rate. Methods: From January 1990 to June 1999, 10 pa- tients with pancreas uncinate process c... Objectives: To analyze the clinical features of unci- nate process carcinoma of the pancreas and to im- prove the resection rate. Methods: From January 1990 to June 1999, 10 pa- tients with pancreas uncinate process carcinoma re- ceived Whipple's operation. Portal vein (PV) resec- tion and reanastomosis were performed in 5 patients, and the resected length varied from 2.0 to 4.2 cm. Two patients underwent PV lateral wall partial resec- tion. Results: Among the 7 patients undergoing PV resec- tion, 1 died of hepatic failure 3 days after operation. One patient suffered from postoperative chylous asci- tes. These 6 patients survived 13 to 29 months post- operatively. Among the 3 patients without PV resec- tion, 2 survived 13 months and 14 months respective- ly. One patient was alive by the end of follow-up for 11. 5 months postoperatively. Conclusion: Although uncinate process carcinoma of the pancreas has a tendency to invade the adjacent PV and superior mesentery vein, it should not be simply regarded as a contraindication of radical resection. 展开更多
关键词 pancreas neoplasms uncinate process pancreaticoduodenectomy
下载PDF
Prognosis of cancer with branch duct type IPMN of the pancreas 被引量:3
4
作者 Nobuhito Ikeuchi Takao Itoi +9 位作者 Atsushi Sofuni Fumihide Itokawa Takayoshi Tsuchiya Toshio Kurihara Kentaro Ishii Shujiro Tsuji Junko Umeda Fuminori Moriyasu Akihiko Tsuchida Kazuhiko Kasuya 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第15期1890-1895,共6页
AIM:To examine the coexistence of metachronous and synchronous cancer in branch duct intraductal papillary mucinous neoplasms of the pancreas (IPMN).METHODS: We reviewed the records of 145 patients with branch duct IP... AIM:To examine the coexistence of metachronous and synchronous cancer in branch duct intraductal papillary mucinous neoplasms of the pancreas (IPMN).METHODS: We reviewed the records of 145 patients with branch duct IPMN between January 1991 and April 2008 and assessed the relationship between IPMN and intraor extra-pancreatic carcinoma and the outcome of IPMN.RESULTS: The mean observation period was 55.9 ± 45.3 mo. Among the 145 patients, the frequency of extra-pancreatic cancer was 29.0%. The frequency of gastric cancer, colon cancer, breast cancer, and pan-creatic cancer were 25.5%, 15.7%, 13.7%, and 9.8%, respectively. Twenty (13.8%) of the patients died. The cause of death was extra-pancreatic carcinoma in 40%,pancreatic cancer in 25%, IPMN per se in 20%, and benign disease in 15% of the patients.CONCLUSION: The prognosis for IPMN depends not on the IPMN per se, but on the presence of intraor extra-pancreatic cancer. 展开更多
关键词 Intraductal papillary mucinous neoplasms of the pancreas Long-term follow-up Extra-pancreatic cancer Pancreatic cancer PROGNOSIS
下载PDF
Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct 被引量:5
5
作者 Yuji Sakai Masayuki Ohtsuka +7 位作者 Harutoshi Sugiyama Rintaro Mikata Shin Yasui Izumi Ohno Yotaro Iino Jun Kato Toshio Tsuyuguchi Naoya Kato 《World Journal of Gastroenterology》 SCIE CAS 2021年第15期1569-1577,共9页
Bile duct epithelial tumours showing papillary neoplasm in the bile duct lumen are present in the intrahepatic and extrahepatic bile ducts.Clinicopathological images of these tumours are distinctive and diverse,includ... Bile duct epithelial tumours showing papillary neoplasm in the bile duct lumen are present in the intrahepatic and extrahepatic bile ducts.Clinicopathological images of these tumours are distinctive and diverse,including histological images with a low to high grade dysplasia,infiltrating and noninfiltrating characteristics,excessive mucus production,and similarity to intraductal papillary mucinous neoplasm(IPMN)of the pancreas.The World Health Organization Classification of Tumours of the Digestive System in 2010 named these features,intraductal papillary neoplasm of the bile duct(IPNB),as precancerous lesion of biliary carcinoma.IPNB is currently classified into type 1 that is similar to IPMN,and type 2 that is not similar to IPMN.Many of IPNB spreads superficially,and diagnosis with cholangioscopy is considered mandatory to identify accurate localization and progression.Prognosis of IPNB is said to be better than normal bile duct cancer. 展开更多
关键词 Intraductal papillary neoplasm of the bile duct Intraductal papillary mucinous neoplasm of the pancreas Peroral cholangioscopy CHOLANGIOSCOPY
下载PDF
胰腺癌中livin、caspase-3的表达及其临床意义 被引量:15
6
作者 杜媛 冯一中 李峰 《临床与实验病理学杂志》 CAS CSCD 北大核心 2009年第6期610-614,共5页
目的探讨livin和caspase-3蛋白在胰腺癌中的表达及其与临床病理参数和预后的相关性及意义。方法应用高通量的组织芯片技术和免疫组化SP法检测88例无术前放化疗史的胰腺癌手术标本和11例非肿瘤性胰腺组织中livin和caspase-3蛋白的表达情... 目的探讨livin和caspase-3蛋白在胰腺癌中的表达及其与临床病理参数和预后的相关性及意义。方法应用高通量的组织芯片技术和免疫组化SP法检测88例无术前放化疗史的胰腺癌手术标本和11例非肿瘤性胰腺组织中livin和caspase-3蛋白的表达情况,运用Spearman秩相关分析两者之间的相关性,并对随访2个月~6年的54例病例作生存分析。结果88例胰腺癌组织中,livin的阳性表达率为76.1%(67/88),而caspase-3在非肿瘤性胰腺组织中的阳性表达率为90.9%(10/11),显著高于胰腺癌组织(40.9%,36/88),差异均有统计学意义(P<0.01);livin表达与患者性别、肿瘤大小、TNM分期及淋巴结转移相关(P<0.05),caspase-3表达与患者性别、组织学分化、TNM分期及淋巴结转移相关(P<0.01);经Spearman秩相关分析显示,livin和caspase-3在胰腺癌中有协同表达(P<0.01);在有随访结果的54例中,单因素COX分析显示,livin表达及淋巴结转移情况与预后相关(P<0.05),caspase-3表达及患者性别、年龄、部位、肿瘤大小、组织学分化程度、TNM分期与预后无关(P>0.05);多因素COX分析显示,只有livin表达具有独立的预后意义(P<0.05)。结论livin表达与胰腺癌临床病理参数及预后密切相关,可作为胰腺癌的独立预后指标,caspase-3可能参与细胞凋亡的调控和胰腺癌生物学进程。 展开更多
关键词 胰腺肿瘤 LIVIN CASPASE-3 组织芯片 免疫组织化学
下载PDF
三维适形放疗联合高强度聚焦超声治疗中晚期胰腺癌临床疗效 被引量:5
7
作者 杜春辉 陆培新 +3 位作者 王连新 张龙 黄锡平 黄桃辉 《中国实用医药》 2012年第13期5-7,共3页
目的观察三维适形放疗(3DCRT)联合高强度聚焦超声(HIFU)治疗中晚期胰腺癌的临床疗效。方法对住院的73例胰腺癌连续病例,随意分为3DCRT+HIFU治疗组(联合治疗组)、3DCRT治疗组(放疗组)和HIFU治疗组3组。联合治疗组先行放疗,30min内接受HIF... 目的观察三维适形放疗(3DCRT)联合高强度聚焦超声(HIFU)治疗中晚期胰腺癌的临床疗效。方法对住院的73例胰腺癌连续病例,随意分为3DCRT+HIFU治疗组(联合治疗组)、3DCRT治疗组(放疗组)和HIFU治疗组3组。联合治疗组先行放疗,30min内接受HIFU治疗。放疗单次剂量为180~200cGy,1次/d,5次/周,总剂量5000~7000cGy;HIFU治疗每次1h,隔天一次,3次/周。结果联合治疗组、放疗组、HIFU治疗组的总有效率分别为63.64%(14/22)、44.83%(13/29)、40.91%(9/22),临床受益率(CBR)分别为95.45%(21/22)、86.21%(25/29)、86.36%(19/22);一、二年生存率分别为59.09%(13/22)、50.00%(11/22),41.38%(12/29)、24.14%(7/29),40、91%(9/22)、22.73%(5/22);中位生存期分别为17.64个月、12.43个月和12.35个月。结论 3DCRT+HIFU治疗胰腺癌具有协同增效作用,能有效的提高中晚期胰腺癌的临床疗效。 展开更多
关键词 胰腺肿瘤 三维适形放疗 高强度聚焦超声
下载PDF
新肿瘤标志CA_(242)对胆胰恶性肿瘤诊断意义 被引量:2
8
作者 宁国礼 李开宗 +1 位作者 付由池 陈铭声 《第四军医大学学报》 1995年第6期446-448,共3页
应用免疫放射分析(IRMA)糖类抗原242(CA_(242))在胆胰恶性肿瘤诊断中的价值,检测66例胆胰恶性肿瘤患者,74例胆胰良性疾病患者血清中CA_(242)含量。其结果CA_(242)分别为33.527±1... 应用免疫放射分析(IRMA)糖类抗原242(CA_(242))在胆胰恶性肿瘤诊断中的价值,检测66例胆胰恶性肿瘤患者,74例胆胰良性疾病患者血清中CA_(242)含量。其结果CA_(242)分别为33.527±19.982U/ml,8.437±5.987U/ml,恶性肿瘤值显著高于良性疾病组(P<0.01).以12U/ml为界值,诊断胆胰恶性肿瘤灵敏度为80.3%,特异度82.4%,为临床较早的诊断胆胰恶性肿瘤提供了重要依据。 展开更多
关键词 肿瘤标志 糖类抗原242 胆道肿瘤 胰腺肿瘤
下载PDF
Use of oral contraceptives and risk of pancreatic cancer in women:A recalculated meta-analysis of prospective cohort studies
9
作者 Jong-Myon Bae 《World Journal of Gastroenterology》 SCIE CAS 2021年第48期8374-8377,共4页
In a recent systematic review and meta-analysis of observational studies,the author found potential errors in the selection and extraction processes.The recalculated summary relative risks and the results of a dose-re... In a recent systematic review and meta-analysis of observational studies,the author found potential errors in the selection and extraction processes.The recalculated summary relative risks and the results of a dose-response metaanalysis showed that oral contraceptive use may not be associated with the risk of pancreatic cancer in women. 展开更多
关键词 pancreas neoplasms Oral contraceptives Risk factor META-ANALYSIS Risk assessment Systematic review
下载PDF
Current surgical management of pancreatic endocrine tumor liver metastases 被引量:5
10
作者 Theodoros E Pavlidis Kyriakos Psarras +2 位作者 Nikolaos G Symeonidis Efstathios T Pavlidis Athanasios K Sakantamis 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2011年第3期243-247,共5页
BACKGROUND: The management of metastatic disease in pancreatic endocrine tumors (PETs) demands a multidisciplinary approach and the cooperation of several medical specialties. The role of surgery is critical, even whe... BACKGROUND: The management of metastatic disease in pancreatic endocrine tumors (PETs) demands a multidisciplinary approach and the cooperation of several medical specialties. The role of surgery is critical, even when a radical excision cannot always be achieved. DATA SOURCES: A PubMed search of relevant articles published up to February 2011 was performed to identify current information about PET liver metastases regarding diagnosis and management, with an emphasis on surgery. RESULTS: The early diagnosis of metastases and their accurate localization, most commonly in the liver, is very important. Surgical options include radical excision, and palliative excision to relieve symptoms in case of failure of medical treatment. The goal of the radical excision is to remove the primary tumor bulk and all liver metastases at the same time, but unfortunately it is not feasible in most cases. Palliative excisions include aggressive tumor debulking surgeries in well-differentiated carcinomas, trying to remove at least 90% of the tumor mass, combined with other additional destructive techniques such as hepatic artery embolization or chemoembolization to treat metastases or chemoembolization to relieve symptoms in cases of rapidly growing tumors. The combination of chemoembolization and systemic chemotherapy results in better response and survival rates. Other local destructive techniques include ethanol injection, cryotherapy and radiofrequency ablation. CONCLUSION: It seems that the current management of PETs can achieve important improvements, even in advanced cases. 展开更多
关键词 pancreatic endocrine tumors pancreas islet cell neoplasms neuroendocrine tumors liver metastases surgical management debulking surgery
下载PDF
Artificial intelligence in pancreatic surgery:current applications
11
作者 Christoph Kuemmerli Fabian Rössler +7 位作者 Caroline Berchtold Michael C.Frey Alexander Studier-Fischer Amila Cizmic Jan Philipp Jonas Thilo Hackert Felix Nickel Philip C.Müller 《Journal of Pancreatology》 2023年第2期74-81,共8页
Surgery plays a central role in the treatment of benign and malignant pancreatic diseases.Artificial intelligence(AI)is an important upcoming technology to support surgeons in pre-,intra-,and postoperative diagnosis,d... Surgery plays a central role in the treatment of benign and malignant pancreatic diseases.Artificial intelligence(AI)is an important upcoming technology to support surgeons in pre-,intra-,and postoperative diagnosis,decision-making and training toward an optimized patient care.Current AI applications show a promising role in the evaluation of preoperative images for prediction of malignancy and resectability,intraoperative decision support,surgical training as well as a postoperative risk stratification to per-sonalize the management of complications.This scoping review summarizes the most up to date developments of AI in pancreatic surgery with the highest available level of evidence. 展开更多
关键词 Artificial intelligence IMAGE-GUIDANCE Machine learning pancreas neoplasms Pancreatic ductal carcinoma Personalized medicine SURGERY
原文传递
超声内镜对胃异位胰腺与间质瘤的鉴别诊断价值 被引量:11
12
作者 宋璇 崔志平 +5 位作者 郝洪升 李文捷 争熏峰 李延青 孙莉娟 陆晓恒 《中华超声影像学杂志》 CSCD 北大核心 2012年第9期775-778,共4页
目的探讨超声内镜在胃异位胰腺与间质瘤鉴别诊断中的价值。方法回顾分析经病理证实的40例胃异位胰腺与141例间质瘤患者的临床资料和超声检查结果,包括病变的部位、大小、起源层次、生长方式、内部回声等。结果胃异位胰腺最常位于胃窦部... 目的探讨超声内镜在胃异位胰腺与间质瘤鉴别诊断中的价值。方法回顾分析经病理证实的40例胃异位胰腺与141例间质瘤患者的临床资料和超声检查结果,包括病变的部位、大小、起源层次、生长方式、内部回声等。结果胃异位胰腺最常位于胃窦部(92.5%),胃间质瘤多位于胃体(45.4%)、胃窦(23.4%)和胃底(22.0%),两者病变部位差异有统计学意义(P〈0.001)。胃异位胰腺与间质瘤在最长/最短直径比值方面差异无统计学意义(P=0.057)。间质瘤与异位胰腺大小差异有统计学意义[(19.98±12.80)mm对(11.25±3.61)mm,P〈0.001)]。异位胰腺多起源于第3层(黏膜下层,75%),间质瘤常起源于第4层(固有肌层,54.6%)和第2层(黏膜肌层,34.0%),两者起源层次差异有统计学意义(P〈0.001)。异位胰腺以肌壁内生长为主(82.5%),问质瘤以肌壁内生长(37.6%)、腔外生长(24.8%)和腔内生长(22.7%)为主,两者生长方式差异有统计学意义(P〈0.001)。内部回声方面,异位胰腺以低回声(32.5%)、中等回声(27.5%)和混合回声(27.5%)为主,间质瘤多为均匀低回声(72.3%)。结论超声内镜下异位胰腺与间质瘤在病变部位、大小、起源层次、生长方式和回声方式上差异有统计学意义,对胃异位胰腺和问质瘤的鉴别有重要价值。 展开更多
关键词 腔内超声检查 胃肿瘤 胃肠道间质肿瘤 异位胰腺
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部